These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 17605742)

  • 1. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
    Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
    Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia.
    Sempere A; Sanz GF; Senent L; de la Rubia J; Jarque I; López F; Arilla MJ; Guinot M; Martín G; Martínez J
    Bone Marrow Transplant; 1992 Dec; 10(6):495-8. PubMed ID: 1362686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
    Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
    Han CS; Miller W; Haake R; Weisdorf D
    Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
    Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.
    Oshima K; Takahashi T; Mori T; Matsuyama T; Usuki K; Asano-Mori Y; Nakahara F; Okamoto S; Kurokawa M; Kanda Y
    Transpl Infect Dis; 2010 Oct; 12(5):421-7. PubMed ID: 20626711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue.
    Bilgrami S; Chakraborty NG; Rodriguez-Pinero F; Khan AM; Feingold JM; Bona RD; Edwards RL; Dorsky D; Clive J; Mukherji B; Tutschka PJ
    Bone Marrow Transplant; 1999 Mar; 23(5):469-74. PubMed ID: 10100561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
    König C; Kleber M; Reinhardt H; Knop S; Wäsch R; Engelhardt M
    Ann Hematol; 2014 Mar; 93(3):479-84. PubMed ID: 24318541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir and renal transplantation.
    Pettersson E; Eklund B; Höckerstedt K; Salmela K; Ahonen J
    Scand J Infect Dis Suppl; 1985; 47():145-8. PubMed ID: 3912970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir prophylaxis in bone marrow transplant recipients.
    Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
    Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Varicella-zoster virus infection after peripheral blood stem cell autografts in children with leukemia or non-Hodgkin's lymphoma].
    Okamoto Y; Takaue Y; Saito S; Hirao A; Suzue T; Shimizu T; Abe T; Sato J; Watanabe T; Kawano Y
    Rinsho Ketsueki; 1992 Sep; 33(9):1204-9. PubMed ID: 1359169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella-zoster virus infections after autologous bone marrow transplantation in children.
    Wacker P; Hartmann O; Benhamou E; Salloum E; Lemerle J
    Bone Marrow Transplant; 1989 Mar; 4(2):191-4. PubMed ID: 2650789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.
    Perren TJ; Powles RL; Easton D; Stolle K; Selby PJ
    Am J Med; 1988 Aug; 85(2A):99-101. PubMed ID: 3044103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.